Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹22,110 Cr
Revenue (TTM)
₹2,663 Cr
Net Profit (TTM)
₹528 Cr
ROE
25.2 %
ROCE
31.5 %
P/E Ratio
41.9
P/B Ratio
8.6
Industry P/E
42.05
EV/EBITDA
24.5
Div. Yield
0.9 %
Debt to Equity
0
Book Value
₹153
EPS
₹59
Face value
10
Shares outstanding
167,555,020
CFO
₹3,434.43 Cr
EBITDA
₹4,138.09 Cr
Net Profit
₹2,631.02 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| -10.9 | -6.2 | -5.1 | 3.2 | 13.1 | 1.0 | 11.1 |
|
BSE Healthcare
| -2.7 | -1.8 | -3.9 | 3.1 | 25.2 | 15.5 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| -2.9 | 16.5 | 14.0 | -40.9 | 58.8 | 50.3 | 61.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
|
1,320.9 | 22,109.7 | 2,662.8 | 533.1 | 22.9 | 24.1 | 41.9 | 8.6 |
| 143.0 | 81.5 | 49.6 | 5.3 | 11.7 | 13.8 | 15.5 | 2.3 | |
| 642.0 | 25,628.9 | 3,626.9 | 315.0 | 15.0 | 13.3 | 85.2 | 11.0 | |
| 593.0 | 1,941.5 | 766.3 | 80.5 | 15.7 | 8.9 | 24.2 | 2.1 | |
| 263.2 | 359.2 | 166.7 | 7.2 | 3.9 | 3.9 | 38.1 | 1.3 | |
| 445.0 | 9,123.5 | 1,566.5 | 169.5 | 14.8 | 12.7 | 54.2 | 1.5 | |
| 281.0 | 904.1 | 1,231.3 | 29.1 | -4.7 | 4 | 34.7 | 1.3 | |
| 257.0 | 1,323.4 | 294.1 | 32.4 | 17.4 | 15.1 | 39.7 | 5.6 | |
| 365.8 | 5,853.3 | 792.3 | 135.5 | 23.5 | 26.4 | 42.5 | 8.8 | |
| 916.1 | 8,867.9 | 768.1 | 159.9 | 29.2 | 19.3 | 55.6 | 9.8 |
The Backing of a Resilient Balance Sheet
5 min read•By Jugal Harpalani
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology,... electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India. Read more
Incorporated
1995
Chairman
Arvind Lal
Managing Director
--
Group
Arvind Lal
Headquarters
New Delhi, Delhi
Website
Looking for more details about Dr. Lal Pathlabs Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Dr Lal Pathlabs Ltd is ₹1,320.90 (NSE) and ₹1,321.05 (BSE) as of 20-Mar-2026 11:09 IST. Dr Lal Pathlabs Ltd has given a return of 13.05% in the last 3 years.
The P/E ratio of Dr Lal Pathlabs Ltd is 41.85 times as on 20-Mar-2026, a 0 discount to its peers’ median range of 42.05 times.
The P/B ratio of Dr Lal Pathlabs Ltd is 8.63 times as on 20-Mar-2026, a 20 premium to its peers’ median range of 7.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
42.52
|
9.79
|
|
2024
|
52.80
|
10.50
|
|
2023
|
63.80
|
9.48
|
|
2022
|
63.02
|
15.06
|
|
2021
|
77.38
|
18.72
|
The 52-week high and low of Dr Lal Pathlabs Ltd are Rs 1,770.00 and Rs 1,175.78 as of 20-Mar-2026.
Dr Lal Pathlabs Ltd has a market capitalisation of ₹ 22,110 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dr Lal Pathlabs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-4.50
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.